[go: up one dir, main page]

FR3104957B1 - Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate et un dérivé 4-hydroxybenzylidène-malonate ou 4-hydroxy-cinnamate - Google Patents

Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate et un dérivé 4-hydroxybenzylidène-malonate ou 4-hydroxy-cinnamate Download PDF

Info

Publication number
FR3104957B1
FR3104957B1 FR1915117A FR1915117A FR3104957B1 FR 3104957 B1 FR3104957 B1 FR 3104957B1 FR 1915117 A FR1915117 A FR 1915117A FR 1915117 A FR1915117 A FR 1915117A FR 3104957 B1 FR3104957 B1 FR 3104957B1
Authority
FR
France
Prior art keywords
derivative
composition
cyanodiphenylacrylate
alpha
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1915117A
Other languages
English (en)
Other versions
FR3104957A1 (fr
Inventor
Martin Josso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1915117A priority Critical patent/FR3104957B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to BR112022011869-4A priority patent/BR112022011869B1/pt
Priority to EP20816984.7A priority patent/EP4076677A1/fr
Priority to US17/784,181 priority patent/US12453682B2/en
Priority to PCT/EP2020/084500 priority patent/WO2021122039A1/fr
Priority to JP2022537166A priority patent/JP2023506933A/ja
Publication of FR3104957A1 publication Critical patent/FR3104957A1/fr
Application granted granted Critical
Publication of FR3104957B1 publication Critical patent/FR3104957B1/fr
Priority to JP2024043608A priority patent/JP2024071451A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/63—More than one coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate, et un dérivé 4-hydroxybenzylidènemalonate La présente invention concerne une composition comprenant :1) au moins un filtre UV inorganique choisi parmi les oxydes de titane ;2) au moins un dérivé de alpha-cyanodiphénylacrylate de formule déterminée ; et3) au moins un dérivé de 4-hydroxy-benzylidene malonate ou de 4-hydroxy-cinnamate de formule déterminée. La présente invention concerne également une méthode de traitement cosmétique de la peau contre le rayonnement UV mettant en œuvre ladite composition.
FR1915117A 2019-12-20 2019-12-20 Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate et un dérivé 4-hydroxybenzylidène-malonate ou 4-hydroxy-cinnamate Active FR3104957B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1915117A FR3104957B1 (fr) 2019-12-20 2019-12-20 Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate et un dérivé 4-hydroxybenzylidène-malonate ou 4-hydroxy-cinnamate
EP20816984.7A EP4076677A1 (fr) 2019-12-20 2020-12-03 Composition comprenant au moins 5 % en poids d'oxydes de titane, un dérivé a-cyanodiphénylacrylate et un dérivé de 4-hydroxybenzylidènemalonate ou de 4-hydroxycinnamate
US17/784,181 US12453682B2 (en) 2019-12-20 2020-12-03 Composition comprising at least 5% by weight of titanium oxides, an α-cyanodiphenylacrylate derivative and a 4-hydroxybenzylidenemalonate or 4-hydroxycinnamate derivative
PCT/EP2020/084500 WO2021122039A1 (fr) 2019-12-20 2020-12-03 Composition comprenant au moins 5 % en poids d'oxydes de titane, un dérivé a-cyanodiphénylacrylate et un dérivé de 4-hydroxybenzylidènemalonate ou de 4-hydroxycinnamate
BR112022011869-4A BR112022011869B1 (pt) 2019-12-20 2020-12-03 Composição, método cosmético para tratar a pele e uso da composição
JP2022537166A JP2023506933A (ja) 2019-12-20 2020-12-03 少なくとも５質量％の酸化チタン、α－シアノジフェニルアクリレート誘導体、及び４－ヒドロキシベンジリデンマロネート又は４－ヒドロキシシンナメート誘導体を含む組成物
JP2024043608A JP2024071451A (ja) 2019-12-20 2024-03-19 少なくとも５質量％の酸化チタン、α－シアノジフェニルアクリレート誘導体、及び４－ヒドロキシベンジリデンマロネート又は４－ヒドロキシシンナメート誘導体を含む組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1915117 2019-12-20
FR1915117A FR3104957B1 (fr) 2019-12-20 2019-12-20 Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate et un dérivé 4-hydroxybenzylidène-malonate ou 4-hydroxy-cinnamate

Publications (2)

Publication Number Publication Date
FR3104957A1 FR3104957A1 (fr) 2021-06-25
FR3104957B1 true FR3104957B1 (fr) 2022-08-05

Family

ID=69811311

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1915117A Active FR3104957B1 (fr) 2019-12-20 2019-12-20 Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate et un dérivé 4-hydroxybenzylidène-malonate ou 4-hydroxy-cinnamate

Country Status (5)

Country Link
US (1) US12453682B2 (fr)
EP (1) EP4076677A1 (fr)
JP (2) JP2023506933A (fr)
FR (1) FR3104957B1 (fr)
WO (1) WO2021122039A1 (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753295B1 (fr) 1995-07-13 1998-04-08 L'oreal Utilisation de particules creuses déformables contre le photobleuissement et/ou le blanchiment d'une composition cosmétique et/ou dermatologique contenant des pigments d'oxyde de titane
FR2736543B1 (fr) 1995-07-13 1997-08-29 Oreal Compositions cosmetiques anhydres contenant des nanopigments de ti02 et des microspheres creuses deformables
FR2739555B1 (fr) 1995-10-04 1998-01-02 Oreal Compositions cosmetiques photoprotectrices contenant des nanopigments de tio2 et un acylaminoacide
FR2746311B1 (fr) * 1996-03-22 1998-04-17 Oreal Procede de reduction du photobleuissement d'une composition cosmetique contenant des pigments d'oxyde de titane, compositions et utilisations
EP1798213A1 (fr) 2005-12-14 2007-06-20 Cognis IP Management GmbH Procédé pour la production d'hydrocarbures
WO2008155059A2 (fr) 2007-06-19 2008-12-24 Cognis Ip Management Gmbh Mélanges d'hydrocarbures et leur utilisation
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
WO2015126874A1 (fr) * 2014-02-18 2015-08-27 R.P. Scherer Technologies, Llc Formulation anhydre topique de remplissage pour filtres anti-ultraviolets
US10813870B2 (en) * 2018-09-28 2020-10-27 L'oreal Mineral sunscreen compositions with improved efficacy

Also Published As

Publication number Publication date
US20230044544A1 (en) 2023-02-09
WO2021122039A1 (fr) 2021-06-24
JP2023506933A (ja) 2023-02-20
US12453682B2 (en) 2025-10-28
EP4076677A1 (fr) 2022-10-26
BR112022011869A2 (pt) 2022-09-06
FR3104957A1 (fr) 2021-06-25
JP2024071451A (ja) 2024-05-24

Similar Documents

Publication Publication Date Title
EP4356973A3 (fr) Dérivés de 6-(4-amino-3-méthyl-2-oxa-8-azaspiro[4.5!décan-8-yl)-3-(2,3-dichlorophényl)-2-méthylpyrimidin-4(3h)-one et composés apparentés en tant qu'inhibiteurs de ptpn11 (shp2)
ZA202403924B (en) Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators
MX2024000780A (es) Anticuerpo anti-pd-1 para usarse en el tratamiento de cancer de pulmon.
MX2022014914A (es) Compuestos de interaccion con glicanos y metodos de uso.
ZA202202363B (en) Antibodies against ilt2 and use thereof
CR20210544A (es) DERIVADOS DE 1,1-DIÓXIDO DE 3-AMINO-4H-BENZO[E][1,2,4] tiadiazina COMO INHIBIDORES DE MRGX2
MX2020008736A (es) Formulaciones de anticuerpos b7-h4.
JOP20210164A1 (ar) طرق وتركيبات علاج السرطان
MX2020012107A (es) Composiciones y procedimientos para el tratamiento del cancer.
MA40378B1 (fr) Procédé de préparation d'intermédiaires synthétiques pour la préparation de dérivés de la tétrahydroquinoléine
BRPI0414267A (pt) polipeptìdeos de campilobacter e métodos de uso
MX2021008510A (es) Derivados de tiazolopiridina como antagonistas del receptor de adenosina.
MA55981B1 (fr) Antibiotiques macrocycliques à large spectre
MX2020012613A (es) Composiciones y usos de las mismas para el tratamiento de enfermedades o afecciones.
PH12022550491A1 (en) Perk inhibiting pyrrolopyrimidine compounds
EA202191058A1 (ru) Антитела против муцина-16 и способы их применения
MX2020012281A (es) Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas.
MX2024006243A (es) Compuestos que contienen heteroatomos y usos de estos.
MX2023004008A (es) Derivados de tetrazol como inhibidores de trpa1.
FR3104957B1 (fr) Composition comprenant au moins 5 % en poids d’oxydes de titane, un dérivé alpha-cyanodiphénylacrylate et un dérivé 4-hydroxybenzylidène-malonate ou 4-hydroxy-cinnamate
MX2019007041A (es) Metodos y composiciones para tratar la enfermedad de parkinson.
EA202192192A1 (ru) Способ лечения или профилактики рака путем целенаправленного воздействия на внеклеточную часть кератина 14 (krt14), присутствующую на раковых клетках
FR3042409B1 (fr) Emulsion comprenant une charge a effet flouteur et un pigment composite a base d'alumine plaquettaire, d'oxyde metallique et d'un agent de traitement de surface
FR3081686B1 (fr) Composition alimentaire comprenant de la phycocyanine
WO2006091965A3 (fr) Nod1 utilise en tant qu'agent antitumoral

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210625

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7